DOAJ
Open Access
2022
P359: IMPROVED OVERALL SURVIVAL AND MRD CLEARANCE WITH BLINATUMOMAB VS CHEMOTHERAPY AS PRE-TRANSPLANT CONSOLIDATION IN PEDIATRIC HIGH-RISK FIRST-RELAPSE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
F. Locatelli
G. Zugmaier
C. Rizzari
J. Morris
B. Gruhn
+17 lainnya
Topik & Kata Kunci
Penulis (22)
F
F. Locatelli
G
G. Zugmaier
C
C. Rizzari
J
J. Morris
B
B. Gruhn
T
T. Klingebiel
R
R. Parasole
C
C. Linderkamp
C
C. Flotho
A
A. Petit
C
C. Micalizzi
Y
Y. Zeng
R
R. Desai
W
W. Kormany
C
C. Eckert
A
A. Möricke
M
M. Sartor
O
O. Hrusak
C
C. Peters
V
V. Saha
L
L. Vinti
A
A. von Stackelberg
Format Sitasi
Locatelli, F., Zugmaier, G., Rizzari, C., Morris, J., Gruhn, B., Klingebiel, T. et al. (2022). P359: IMPROVED OVERALL SURVIVAL AND MRD CLEARANCE WITH BLINATUMOMAB VS CHEMOTHERAPY AS PRE-TRANSPLANT CONSOLIDATION IN PEDIATRIC HIGH-RISK FIRST-RELAPSE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL). https://doi.org/10.1097/01.HS9.0000844324.04051.5b
Akses Cepat
PDF tidak tersedia langsung
Cek di sumber asli →Informasi Jurnal
- Tahun Terbit
- 2022
- Sumber Database
- DOAJ
- DOI
- 10.1097/01.HS9.0000844324.04051.5b
- Akses
- Open Access ✓